ENTITY

Genfit (GNFT US)

1
Analysis
Health Care • France
Genfit operates as a biopharmaceutical company. The Company focuses on the discovery and development of drug candidates and innovative diagnostic solutions. Genfit targets metabolic diseases and liver pathologies associated with them.
more
bullish•Alibaba
•07 Dec 2020 06:26

House Passes "Delisting Act" Giving SEC 90 Days to Write Its Rules (And Yes, More Bark Than Bite)

The U.S. House of Representatives passed Senate Bill 945, the "Holding Foreign Companies Accountable Act." New details support the notion that S945...

Logo
476 Views
Share
No more insights
x